US Stock MarketDetailed Quotes
DRIO DarioHealth
- 1.200
- +0.030+2.56%
Close Jul 19 16:00 ET
- 1.220
- +0.020+1.67%
Post 16:03 ET
35.91MMarket Cap-714P/E (TTM)
1.260High1.155Low39.15KVolume1.160Open1.170Pre Close47.09KTurnover0.16%Turnover RatioLossP/E (Static)29.92MShares3.82052wk High0.46P/B28.92MFloat Cap0.68052wk Low--Dividend TTM24.10MShs Float5579.991Historical High--Div YieldTTM9.01%Amplitude0.680Historical Low1.202Avg Price1Lot Size
DarioHealth Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -175.59%-13.11M | 36.51%-30.38M | 7.56%-7.34M | 19.17%-8.65M | 13.31%-9.64M | 73.71%-4.76M | 5.09%-47.85M | 47.54%-7.94M | 13.99%-10.7M | 9.68%-11.12M |
| Net income from continuing operations | 44.05%-7.18M | 4.45%-59.43M | -13.22%-14.29M | -0.64%-15.73M | 8.00%-16.59M | 19.42%-12.83M | 18.98%-62.19M | 41.55%-12.62M | 30.35%-15.63M | -1.48%-18.03M |
| Operating gains losses | -11,376.25%-9.18M | ---- | ---- | ---- | ---- | ---80K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 9.59%1.33M | 5.68%4.99M | 5.60%1.32M | 0.82%1.24M | 0.91%1.22M | 17.13%1.21M | 5.83%4.72M | 43.02%1.25M | -47.70%1.23M | 51.00%1.21M |
| Other non cash items | 61.23%-88K | -91.90%288K | -154.30%-979K | -142.01%-234K | 4.92%1.73M | 49.78%-227K | 806.76%3.56M | --1.8M | --557K | 342.74%1.65M |
| Change In working capital | -310.05%-4.85M | 137.38%4.07M | 251.93%2.21M | 152.26%926K | -419.35%-1.37M | 128.50%2.31M | -323.59%-10.9M | -554.95%-1.45M | -204.47%-1.77M | 136.51%429K |
| -Change in receivables | -219.80%-3.27M | 155.49%2.84M | 162.95%1.28M | 163.58%440K | -166.34%-1.61M | 156.65%2.73M | -1,292.10%-5.11M | -477.47%-2.03M | -18.09%-692K | 387.54%2.42M |
| -Change in inventory | -86.47%146K | 267.48%2.89M | 310.82%409K | -24.27%443K | 270.74%963K | 169.39%1.08M | 22.51%-1.73M | 91.66%-194K | 963.64%585K | -872.60%-564K |
| -Change in payables and accrued expense | -80.38%-1.91M | 64.72%-1.45M | -70.64%128K | 110.11%161K | 49.33%-676K | 34.20%-1.06M | -2,007.44%-4.1M | -72.46%436K | -3,284.00%-1.59M | -403.40%-1.33M |
| -Change in other current assets | 313.89%149K | 126.01%239K | 134.38%11K | 109.67%93K | 45.59%99K | 414.29%36K | -535.55%-919K | -143.24%-32K | -1,436.11%-962K | 15.25%68K |
| -Change in other current liabilities | 76.92%-18K | -114.89%-124K | 118.18%72K | -111.80%-106K | 83.10%-12K | -188.89%-78K | 440.00%833K | 145.83%33K | 1,266.23%898K | -12.70%-71K |
| -Change in other working capital | 113.16%52K | -358.40%-323K | -5.15%313K | -1,066.67%-105K | -44.68%-136K | -287.25%-395K | 179.62%125K | 1,933.33%330K | 90.63%-9K | 30.88%-94K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -175.59%-13.11M | 36.51%-30.38M | 7.56%-7.34M | 19.17%-8.65M | 13.31%-9.64M | 73.71%-4.76M | 5.09%-47.85M | 47.54%-7.94M | 13.99%-10.7M | 9.68%-11.12M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -102.93%-8.85M | 4.54%-547K | -40.68%-83K | -61.49%-281K | 2,728.30%4.18M | -2,309.94%-4.36M | 92.96%-573K | 86.71%-59K | -79.38%-174K | 96.85%-159K |
| Net PPE purchase and sale | 24.32%-56K | -32.13%-584K | -93.02%-83K | -61.49%-281K | 8.18%-146K | -12.12%-74K | -69.35%-442K | 36.76%-43K | -81.25%-174K | -448.28%-159K |
| Net intangibles purchase and sale | ---- | --0 | --0 | ---- | ---- | ---- | ---131K | ---16K | ---- | ---- |
| Net business purchase and sale | ---8.8M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --0 |
| Net investment purchase and sale | --0 | --37K | --0 | --0 | --4.33M | ---4.29M | --0 | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -102.93%-8.85M | 4.54%-547K | -40.68%-83K | -61.49%-281K | 2,728.30%4.18M | -2,309.94%-4.36M | 92.96%-573K | 86.71%-59K | -79.38%-174K | 96.85%-159K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,554.72%20.21M | -70.53%18.25M | 0 | 204K | -17.82%19.44M | -103.65%-1.39M | -5.82%61.94M | 265K | 0 | 42,903.64%23.65M |
| Net issuance payments of debt | --0 | -92.55%1.77M | --0 | --0 | -86.71%3.16M | ---1.39M | --23.79M | --0 | --0 | --23.79M |
| Net common stock issuance | ---- | -95.77%1.61M | --0 | --204K | ---- | ---- | -41.19%38.15M | --265K | --0 | ---134K |
| Net preferred stock issuance | --20.21M | --14.87M | --0 | --0 | --14.87M | --0 | --0 | --0 | --0 | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,554.72%20.21M | -70.53%18.25M | --0 | --204K | -17.82%19.44M | -103.65%-1.39M | -5.82%61.94M | --265K | --0 | 42,903.64%23.65M |
| Net cash flow | ||||||||||
| Beginning cash position | -25.62%36.8M | 37.62%49.47M | -22.70%44.22M | -22.23%52.94M | -30.05%38.96M | 37.62%49.47M | 25.15%35.95M | 11.02%57.21M | 6.27%68.07M | -31.55%55.7M |
| Current changes in cash | 83.29%-1.76M | -193.72%-12.67M | 4.02%-7.42M | 19.75%-8.72M | 12.95%13.98M | -153.21%-10.51M | 87.21%13.52M | 50.35%-7.74M | 13.27%-10.87M | 171.53%12.38M |
| End cash Position | -10.06%35.04M | -25.62%36.8M | -25.62%36.8M | -22.70%44.22M | -22.23%52.94M | -30.05%38.96M | 37.62%49.47M | 37.62%49.47M | 11.02%57.21M | 6.27%68.07M |
| Free cash flow | -172.53%-13.17M | 36.05%-30.96M | 7.20%-7.42M | 18.74%-8.93M | 13.23%-9.78M | 73.40%-4.83M | 4.44%-48.42M | 47.38%-8M | 12.35%-10.98M | 8.60%-11.27M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg